Sigma-Aldrich Investor Relations Sigma-Aldrich Investor Home Home Sigma-Aldrich home page



Investor Relations

Corporate Profile

Sigma-Aldrich, a leading Life Science and Technology company focused on enhancing human health and safety, manufactures and distributes 230,000 chemicals, biochemicals and other essential products and 40,000 equipment products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets.  With three distinct business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is committed to enabling science to improve the quality of life.  The Company operates in 37 countries, has approximately 9,000 employees worldwide and had sales of $2.7 billion in 2013.  For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.

Recent Releases

Jul 23, 2015
Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials

Jun 15, 2015
Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives Approval from European Union Regulators and from Chinese Ministry of Commerce

Jun 11, 2015
Sigma-Aldrich® Named to Newsweek's 2015 Green Rankings

View all releases »


Featured Documents
 

© 2015 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher